Published in Invest Ophthalmol Vis Sci on December 30, 2009
Claudins and the modulation of tight junction permeability. Physiol Rev (2013) 2.05
Human retinal pigment epithelium cells as functional models for the RPE in vivo. Invest Ophthalmol Vis Sci (2011) 1.55
Claudin-19 and the barrier properties of the human retinal pigment epithelium. Invest Ophthalmol Vis Sci (2011) 1.07
Effects of proinflammatory cytokines on the claudin-19 rich tight junctions of human retinal pigment epithelium. Invest Ophthalmol Vis Sci (2012) 0.97
RPE barrier breakdown in diabetic retinopathy: seeing is believing. J Ocul Biol Dis Infor (2011) 0.92
Cultured primary human fetal retinal pigment epithelium (hfRPE) as a model for evaluating RPE metabolism. Exp Eye Res (2014) 0.86
Vascular endothelial growth factor modulates the function of the retinal pigment epithelium in vivo. Invest Ophthalmol Vis Sci (2014) 0.84
Regulation of claudins in blood-tissue barriers under physiological and pathological states. Tissue Barriers (2013) 0.84
The multifactorial nature of retinal vascular disease. Ophthalmologica (2010) 0.82
Engineering a blood-retinal barrier with human embryonic stem cell-derived retinal pigment epithelium: transcriptome and functional analysis. Stem Cells Transl Med (2013) 0.81
Effects of anti-VEGF agents on rat retinal Müller glial cells. Mol Vis (2010) 0.80
Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients. Eye (Lond) (2015) 0.78
Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: clinical and molecular characteristics. Clin Kidney J (2015) 0.78
Mechanism of blood-retinal barrier breakdown induced by HIV-1 (Review). Exp Ther Med (2014) 0.77
The effects of anti-vascular endothelial growth factor agents on human retinal pigment epithelial cells under high glucose conditions. Int J Ophthalmol (2017) 0.75
Effects of Ranibizumab and Aflibercept on Human Müller Cells and Photoreceptors under Stress Conditions. Int J Mol Sci (2017) 0.75
Subretinal recombinant tissue plasminogen activator and pneumatic displacement for the management of subretinal hemorrhage occurring after anti-VEGF injections for wet AMD. Clin Ophthalmol (2011) 0.75
Magnetic nanoparticles: a strategy to target the choroidal layer in the posterior segment of the eye. Sci Rep (2017) 0.75
Enteral feeding and its impact on the gut immune system and intestinal mucosal barrier. Prz Gastroenterol (2015) 0.75
Ranibizumab for neovascular age-related macular degeneration. N Engl J Med (2006) 30.63
Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med (2006) 20.84
The retinal pigment epithelium in visual function. Physiol Rev (2005) 8.59
Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (1989) 8.10
Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol (2004) 5.14
Ionic selectivity revisited: the role of kinetic and equilibrium processes in ion permeation through channels. J Membr Biol (1983) 5.00
Claudins and epithelial paracellular transport. Annu Rev Physiol (2006) 4.79
Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol (1984) 4.68
Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors. PLoS One (2008) 3.46
Barrier function of epithelia. Am J Physiol (1981) 3.21
Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci U S A (1999) 3.19
Age-related macular degeneration is the leading cause of blindness... JAMA (2004) 3.18
Morphological factors influencing transepithelial permeability: a model for the resistance of the zonula occludens. J Membr Biol (1978) 3.02
Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet (2006) 2.96
Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci (2006) 2.74
Endocytosis in filter-grown Madin-Darby canine kidney cells. J Cell Biol (1989) 2.65
The density of small tight junction pores varies among cell types and is increased by expression of claudin-2. J Cell Sci (2008) 2.36
Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci U S A (1990) 2.31
Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J Clin Invest (2008) 2.24
A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers. Mol Vis (2001) 2.09
High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 2.03
Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol (2007) 1.90
Two splice variants of claudin-10 in the kidney create paracellular pores with different ion selectivities. Am J Physiol Renal Physiol (2006) 1.84
Study of claudin function by RNA interference. J Biol Chem (2006) 1.78
Macular edema. Surv Ophthalmol (2004) 1.70
Penetration of bevacizumab through the retina after intravitreal injection in the monkey. Invest Ophthalmol Vis Sci (2007) 1.64
Control of chemokine gradients by the retinal pigment epithelium. Invest Ophthalmol Vis Sci (2008) 1.55
Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells. Mol Vis (2006) 1.50
Claudin-10 exists in six alternatively spliced isoforms that exhibit distinct localization and function. J Cell Sci (2009) 1.39
Development and role of tight junctions in the retinal pigment epithelium. Int Rev Cytol (2007) 1.39
The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration. Prog Retin Eye Res (2008) 1.38
A claudin-9-based ion permeability barrier is essential for hearing. PLoS Genet (2009) 1.29
Effects of brefeldin A on endocytosis, transcytosis and transport to the Golgi complex in polarized MDCK cells. J Cell Biol (1992) 1.28
VEGF modulation of retinal pigment epithelium resistance. Exp Eye Res (2007) 1.25
Vascular endothelial growth factor increases fenestral permeability in hepatic sinusoidal endothelial cells. Liver Int (2003) 1.24
Interleukin-1beta and barrier function of retinal pigment epithelial cells (ARPE-19): aberrant expression of junctional complex molecules. Invest Ophthalmol Vis Sci (2003) 1.22
A novel serum-free method for culturing human prenatal retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2008) 1.21
Characterization of barrier properties and inducible VEGF expression of several types of retinal pigment epithelium in medium-term culture. Curr Eye Res (2006) 1.20
Effects of culture conditions on heterogeneity and the apical junctional complex of the ARPE-19 cell line. Invest Ophthalmol Vis Sci (2006) 1.19
Intravitreal use of bevacizumab (Avastin) for choroidal neovascularization due to ARMD: a preliminary multifocal-ERG and OCT study. Multifocal-ERG after use of bevacizumab in ARMD. Doc Ophthalmol (2007) 1.08
Analysis of the RPE transcriptome reveals dynamic changes during the development of the outer blood-retinal barrier. Mol Vis (2007) 1.06
Aldosterone and tight junctions: modulation of claudin-4 phosphorylation in renal collecting duct cells. Am J Physiol Cell Physiol (2005) 1.00
Effect of temperature on the occluding junctions of monolayers of epithelioid cells (MDCK). J Membr Biol (1984) 0.99
Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin. Invest Ophthalmol Vis Sci (2008) 0.96
VEGF differentially regulates transcription and translation of ZO-1alpha+ and ZO-1alpha- and mediates trans-epithelial resistance in cultured endothelial and epithelial cells. Cell Tissue Res (2005) 0.96
Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells. Am J Physiol Gastrointest Liver Physiol (2002) 0.95
Apical and basal regulation of the permeability of the retinal pigment epithelium. Invest Ophthalmol Vis Sci (2003) 0.92
RPE cells modulate subretinal neovascularization, but do not cause regression in mice with sustained expression of VEGF. Invest Ophthalmol Vis Sci (2003) 0.90
Epithelium-capillary interactions in the eye: the retinal pigment epithelium and the choriocapillaris. Int Rev Cytol (1989) 0.90
PlGF-1 and VEGFR-1 pathway regulation of the external epithelial hemato-ocular barrier. A model for retinal edema. Ophthalmic Res (2008) 0.87
Concentration of vascular endothelial growth factor in the subretinal fluid of retinal detachment. J Ocul Pharmacol Ther (2000) 0.83
Diffusible retinal secretions regulate the expression of tight junctions and other diverse functions of the retinal pigment epithelium. Mol Vis (2008) 0.83
[Concentration of vascular endothelial growth factor within the subretinal space and vitreous fluid in rhegmatogenous retinal detachment]. Nippon Ganka Gakkai Zasshi (1997) 0.81
Evaluation of the clinical age-related maculopathy staging system. Ophthalmology (2006) 2.63
Inverted internal limiting membrane flap technique for large macular holes. Ophthalmology (2010) 2.52
Angiophagy prevents early embolus washout but recanalizes microvessels through embolus extravasation. Sci Transl Med (2014) 2.11
Predicting response to glaucoma therapy in one eye based on response in the fellow eye: the monocular trial. Arch Ophthalmol (2008) 1.66
Acute syphilitic posterior placoid chorioretinitis: report of a case series and comprehensive review of the literature. Retina (2012) 1.58
Is intravitreal bevacizumab an effective treatment option for nonarteritic anterior ischemic optic neuropathy? J Neuroophthalmol (2012) 1.54
Sympathetic ophthalmia. Graefes Arch Clin Exp Ophthalmol (2008) 1.44
Effects of culture conditions on heterogeneity and the apical junctional complex of the ARPE-19 cell line. Invest Ophthalmol Vis Sci (2006) 1.19
The effectiveness of isobutyl cyanoacrylate tissue adhesive for the treatment of corneal perforations. Am J Ophthalmol (2005) 1.16
Surgical management of pseudophakic retinal detachments: a meta-analysis. Ophthalmology (2006) 1.16
The apical and basal environments of the retinal pigment epithelium regulate the maturation of tight junctions during development. J Cell Sci (2004) 1.09
Claudin-19 and the barrier properties of the human retinal pigment epithelium. Invest Ophthalmol Vis Sci (2011) 1.07
Risk factors for progression to penetrating keratoplasty in patients with keratoconus. Am J Ophthalmol (2005) 1.05
Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization? Graefes Arch Clin Exp Ophthalmol (2008) 1.01
Anatomical instruction and training for professionalism from the 19th to the 21st centuries. Clin Anat (2006) 0.99
TEMPORAL INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE VERSUS CLASSIC INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE: A Comparative Study. Retina (2015) 0.99
Effects of proinflammatory cytokines on the claudin-19 rich tight junctions of human retinal pigment epithelium. Invest Ophthalmol Vis Sci (2012) 0.97
Apical and basal regulation of the permeability of the retinal pigment epithelium. Invest Ophthalmol Vis Sci (2003) 0.92
Aflibercept in the treatment of neovascular age-related macular degeneration in previously treated patients. J Ocul Pharmacol Ther (2014) 0.90
A study of macular hole formation by serial spectral optical coherence tomography. Clin Experiment Ophthalmol (2009) 0.89
Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis. J Ocul Pharmacol Ther (2008) 0.89
Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum: five-year follow-up. Semin Ophthalmol (2012) 0.88
Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy. Clin Ophthalmol (2013) 0.88
Expression of JAM-A, AF-6, PAR-3 and PAR-6 during the assembly and remodeling of RPE tight junctions. Brain Res (2006) 0.87
Factor VII-verteporfin for targeted photodynamic therapy in a rat model of choroidal neovascularization. Invest Ophthalmol Vis Sci (2009) 0.87
Assessment of optic nerve cup-to-disk ratio changes in patients receiving multiple intravitreal injections of antivascular endothelial growth factor agents. Retina (2009) 0.85
Incidence and management of elevated intraocular pressure with antivascular endothelial growth factor agents. Semin Ophthalmol (2013) 0.85
The treatment of recurrent central serous chorioretinopathy with intravitreal bevacizumab. J Ocul Pharmacol Ther (2011) 0.85
Differential expression of claudins in retinas during normal development and the angiogenesis of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (2011) 0.84
Imaging for sympathetic ophthalmia: impact on the diagnosis and management. Int Ophthalmol Clin (2012) 0.84
Effects of music therapy on intravitreal injections: a randomized clinical trial. J Ocul Pharmacol Ther (2012) 0.84
Microbial spectrum and resistance patterns in endophthalmitis: a 21-year (1988-2008) review in northeast United States. J Ocul Pharmacol Ther (2012) 0.83
Diffusible retinal secretions regulate the expression of tight junctions and other diverse functions of the retinal pigment epithelium. Mol Vis (2008) 0.83
Laser in situ keratomileusis outcomes following radial keratotomy, astigmatic keratotomy, photorefractive keratectomy, and penetrating keratoplasty. J Cataract Refract Surg (2005) 0.83
Retinal vascular tortuosity in obstructive sleep apnea. Clin Ophthalmol (2013) 0.82
Ocular trauma resulting from paintball injury. Graefes Arch Clin Exp Ophthalmol (2008) 0.82
Engineering a blood-retinal barrier with human embryonic stem cell-derived retinal pigment epithelium: transcriptome and functional analysis. Stem Cells Transl Med (2013) 0.81
A novel rabbit model for studying RPE transplantation. Invest Ophthalmol Vis Sci (2008) 0.80
How do vitrectomy parameters influence the results of rhegmatogenous retinal detachments repair? EVRS RD Study No. 3. Acta Ophthalmol (2013) 0.79
A study of interactions between pharmaceutical representatives and ophthalmology trainees. Am J Ophthalmol (2009) 0.79
Choroidal neovascularization associated with West Nile virus chorioretinitis. Semin Ophthalmol (2007) 0.79
Proliferation of the ciliary epithelium with retinal neuronal and photoreceptor cell differentiation in human eyes with retinal detachment and proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol (2011) 0.79
Ethambutol neuroretinopathy. Semin Ophthalmol (2007) 0.78
Retinal Progenitor Cells contingents in the adult human eye with retinal injury: a specific differentiation potential according to the localization? Exp Eye Res (2012) 0.77
The 2008 anatomy ceremony: essays. Yale J Biol Med (2009) 0.77
High-altitude retinopathy and optical coherence tomography findings. Semin Ophthalmol (2010) 0.77
Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in Central South China. Ophthalmic Epidemiol (2013) 0.77
Bilateral intraocular foreign bodies simulating crystalline lens. Am J Ophthalmol (2004) 0.75
Prevention and management of complications of regional orbital anesthesia. Middle East J Anaesthesiol (2012) 0.75
Fellow selection criteria. Ophthalmology (2009) 0.75
Angioid streaks in thalassemia intermedia: warning for thromboembolic events. Retin Cases Brief Rep (2009) 0.75
Asymmetric Deep Stromal Keratopathy in a Patient With Multiple Myeloma. Cornea (2017) 0.75
The student's dilemma, liver edition: incorporating the sonographer's language into clinical anatomy education. Anat Sci Educ (2015) 0.75
ASSOCIATION BETWEEN THE VITREOMACULAR INTERFACE AND OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS IN WET AGE-RELATED MACULAR DEGENERATION. Retina (2017) 0.75
Hyperacuity Exam Screens for Choroidal Neovascularization in Age-Related Macular Degeneration on a Mobile Device. Ophthalmic Surg Lasers Imaging Retina (2016) 0.75
Retinal arterial macroaneurysm with blood-staining of the internal limiting membrane and optic nerve. Semin Ophthalmol (2007) 0.75